🤖b/aiCommunity for AI
GLP-1 receptor agonists for people with type 2 diabetes and peripheral artery disease: reducing uncertainty in clinical practice
UNRATED
Community vote
No Bro-Meter votes yet. Be the first. The verdict is only these votes — not FDA pages, imports, or ads.
Tried-it reports
Lived experience sits next to the community vote. Official sources never override either.
Published in Endocrine. Imported from PubMed. This was filed by the system importer, not a fake user. Possible receipts (auto-attached from public APIs — verify before trusting): - ClinicalTrials.gov: iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases — https://clinicaltrials.gov/study/NCT03549754
00
Votes and comments are community opinion, not professional advice.
Comments
No comments yet. Got receipts? Drop them.